Author: Per Lundström
Posts by Per Lundström
Lourdes Cucurull-Sanchez joins Pharmetheus as Scientific Lead for the Quantative Systems Pharmacology (QSP) platform
She brings extensive experience from several positions from large companies within drug development, and has made strong scientific contributions through her work within clinical pharmacology. The addition strengthens the company’s focus on QSP, ensuring continued innovation and latest expertise.
New publication: Pharmacometric analyses distinguished the circadian rhythm, placebo response andnepadutant treatment response for duration of crying and fussing in infants with colic.
New publication: PBPK analysis supports dose selection for a sustained-release 5-FC for improved CM treatment in HIV patients
Pharmetheus passes 100 employees and moves to new office in central Uppsala
Pharmetheus AB has reached a capacity milestone with more than one hundred persons on the team, and relocates to new headquarters next to Uppsala Central Station, a strategic move to accommodate the growing need of its services, driving the expansion of the team.
CAR-T cell therapy is part of the next generation of immuno-oncology treatment
It was Anna’s passion and expertise in these novel therapeutic modalities like CAR-T cells that led her to her current position at Pharmetheus. She can be considered one of the few experts in the field of CAR-T cell modeling, and her review paper “Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modeling” was one of the most downloaded papers last year.
Education for empowerment: Online training in Clinical Pharmacology and Pharmacometrics in French
In a global landscape where language can serve as a barrier to knowledge acquisition, the need for scientific learning material in French is pivotal in many African countries. Pharmetheus’ consultants, primarily those who contributed to the French translation of Pharmacometrics Africa’s Pharmacometrics Self-paced online course, feature as guest speakers.
Attend the third annual Educational Pharmacometrics Summer Symposium (EPSS) on June 25, 2024, in connection to PAGE 2024
Pharmetheus evolves its organization to further promote innovation and growth with additions to its leadership team
Pharmetheus announces an evolved organizational structure with additions in the leadership team, and expands business development to further promote innovation and growth.
Pharmetheus strengthens board of directors with key appointments
Pharmetheus, a leading company in biosimulation and biotech, is pleased to announce the appointment of two esteemed professionals to its Board of Directors, further enhancing the company’s strategic vision and expertise. These appointments, effective immediately, represent an important step forward in Pharmetheus’s commitment to innovation, growth, and excellence.
Pharmetheus appoints Regulatory Affairs Consultant
With an increasing need to optimize and de-risk the drug development process, expertise in regulatory affairs is of the essence. Pharmetheus is growing its capabilities within the field to support clients in increasing the probability of a successful drug development program.